Cerezer VG, Bando SY, Pasternak J, Franzolin MR, Moreira-Filho CA. Phylogenetic analysis of Stenotrophomonas spp. isolates contributes to the identification of nosocomial and community-acquired infections. Biomed Res Int. 2014;2014:151405.

Article  PubMed  PubMed Central  Google Scholar 

Majumdar R, Karthikeyan H, Senthilnathan V, Sugumar S. Review on Stenotrophomonas maltophilia: an emerging Multidrug- resistant opportunistic Pathogen. Recent Pat Biotechnol. 2022;16(4):329–54.

Article  CAS  PubMed  Google Scholar 

Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012;25(1):2–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mojica MF, Humphries R, Lipuma JJ, Mathers AJ, Rao GG, Shelburne SA, Fouts DE, Van Duin D, Bonomo RA. Clinical challenges treating Stenotrophomonas maltophilia infections: an update. JAC Antimicrob Resist. 2022;4(3):dlac040.

Article  PubMed  PubMed Central  Google Scholar 

Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America Guidance on the treatment of AmpC beta-lactamase-producing enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections. Clin Infect Dis. 2022;74(12):2089–114.

Article  CAS  PubMed  Google Scholar 

Cho SY, Kang CI, Kim J, Ha YE, Chung DR, Lee NY, Peck KR, Song JH. Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia? Antimicrob Agents Chemother. 2014;58(1):581–3.

Article  PubMed  PubMed Central  Google Scholar 

Sánchez MB. Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia. Front Microbiol. 2015;6:658.

Article  PubMed  PubMed Central  Google Scholar 

Gibb J, Wong DW. Antimicrobial treatment strategies for Stenotrophomonas maltophilia: a focus on Novel therapies. Antibiot (Basel) 2021, 10(10).

Kullar R, Wenzler E, Alexander J, Goldstein EJC. Overcoming Stenotrophomonas maltophilia Resistance for a more rational Therapeutic Approach. Open Forum Infect Dis. 2022;9(5):ofac095.

Article  PubMed  PubMed Central  Google Scholar 

Chang YT, Lin CY, Chen YH, Hsueh PR. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol. 2015;6:893.

Article  PubMed  PubMed Central  Google Scholar 

Mercier-Darty M, Royer G, Lamy B, Charron C, Lemenand O, Gomart C, Fourreau F, Madec JY, Jumas-Bilak E, Decousser JW. Comparative whole-genome phylogeny of animal, Environmental, and human strains confirms the Genogroup Organization and Diversity of the Stenotrophomonas maltophilia Complex. Appl Environ Microbiol 2020, 86(10).

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.

Article  PubMed  Google Scholar 

Modesti PA, Reboldi G, Cappuccio FP, Agyemang C, Remuzzi G, Rapi S, Perruolo E, Parati G. Settings ESHWGoCRiLR: panethnic differences in blood pressure in Europe: a systematic review and Meta-analysis. PLoS ONE. 2016;11(1):e0147601.

Article  PubMed  PubMed Central  Google Scholar 

DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

Article  CAS  PubMed  Google Scholar 

Becker LM. The effects of exercise versus methylphenidate on attention and behavior in children with attention deficit hyperactivity disorder, predominantly inattentive type. The University of Alabama at Birmingham; 1997.

Sterne JA, Egger M. Regression methods to detect publication and other bias in meta-analysis. Publication bias meta‐analysis: Prev Assess Adjustments 2005:99–110.

Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1–48.

Article  Google Scholar 

Team RC. R Core Team R: a language and environment for statistical computing. Foundation for Statistical Computing; 2020.

Hamdi AM, Fida M, Abu Saleh OM, Beam E. Stenotrophomonas bacteremia antibiotic susceptibility and prognostic determinants: Mayo Clinic 10-year experience. Open Forum Infectious diseases: 2020. Oxford University Press US; 2020. p. ofaa008.

Hanberger H, Erlandsson M, Burman LG, Cars O, Gill H, Lindgren S, Nilsson LE, Olsson-Liljequist B, Walther S. Group I-SS: high antibiotic susceptibility among bacterial pathogens in Swedish ICUs Report from a nation-wide surveillance program using TA90 as a novel index of susceptibility. Scand J Infect Dis. 2004;36(1):24–30.

Article  CAS  PubMed  Google Scholar 

Hanberger H, Nilsson LE, Group SS. High frequency of antibiotic resistance among Gram-negative isolates in intensive care units at 10 Swedish hospitals. Clin Microbiol Infect. 1997;3(2):208–15.

Article  CAS  PubMed  Google Scholar 

Hand E, Davis H, Kim T, Duhon B. Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections. J Antimicrob Chemother. 2016;71(4):1071–5.

Article  CAS  PubMed  Google Scholar 

Herrera-Heredia SA, Pezina-Cantu C, Garza-Gonzalez E, Bocanegra-Ibarias P, Mendoza-Olazaran S, Morfin-Otero R, Camacho-Ortiz A, Villarreal-Trevino L, Rodriguez-Noriega E, Palau-Davila L, et al. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico. J Med Microbiol. 2017;66(8):1102–9.

Article  CAS  PubMed  Google Scholar 

Ho MC, Hsiao CH, Sun MH, Hwang YS, Lai CC, Wu WC, Chen KJ. Antimicrobial susceptibility, minimum inhibitory concentrations, and clinical profiles of Stenotrophomonas maltophilia Endophthalmitis. Microorganisms. 2021;9(9):1840.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoban DJ, Bouchillon SK, Johnson JL, Zhanel GG, Butler DL, Miller LA, Poupard JA, Gemifloxacin Surveillance Study Research G. Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a north American surveillance study. Diagn Microbiol Infect Dis. 2001;40(1–2):51–7.

Article  CAS  PubMed  Google Scholar 

Hoban DJ, Bouchillon SK, Johnson JL, Zhanel GG, Butler DL, Saunders KA, Miller LA, Poupard JA, Surveillance Study Research G. Comparative in vitro potency of amoxycillin-clavulanic acid and four oral agents against recent north American clinical isolates from a global surveillance study. Int J Antimicrob Agents. 2003;21(5):425–33.

Article  CAS  PubMed  Google Scholar 

Hohl P, Frei R, Aubry P. In vitro susceptibility of 33 clinical case isolates of Xanthomonas maltophilia. Inconsistent correlation of agar dilution and of disk diffusion test results. Diagn Microbiol Infect Dis. 1991;14(5):447–50.

Article  CAS  PubMed  Google Scholar 

Hombach M, Bloemberg GV, Bottger EC. Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli. J Antimicrob Chemother. 2012;67(3):622–32.

Article  CAS  PubMed  Google Scholar 

Hotta G, Matsumura Y, Kato K, Nakano S, Yunoki T, Yamamoto M, Nagao M, Ito Y, Takakura S, Ichiyama S. Risk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species. PLoS ONE. 2014;9(11):e112208.

Article  PubMed  PubMed Central  Google Scholar 

Hrbacek J, Cermak P, Zachoval R. Current antibiotic resistance patterns of rare uropathogens: survey from central European Urology Department 2011–2019. BMC Urol. 2021;21(1):61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hsueh P-R, Chen W-H, Luh K-T. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991–2003 at a university hospital in Taiwan. Int J Antimicrob Agents. 2005;26(6):463–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hsueh S-C, Lee Y-J, Huang Y-T, Liao C-H, Tsuji M, Hsueh P-R. In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan. J Antimicrob Chemother. 2019;74(2):380–6.

Article  CAS  PubMed  Google Scholar 

Hu LF, Chang X, Ye Y, Wang ZX, Shao YB, Shi W, Li X, Li JB. Stenotrophomonas maltophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of Sul and dfrA genes in a plasmid-mediated class 1 integron. Int J Antimicrob Agents. 2011;37(3):230–4.

Article  CAS  PubMed  Google Scholar 

Hu LF, Chen GS, Kong QX, Gao LP, Chen X, Ye Y, Li JB. Increase in the prevalence of Resistance determinants to Trimethoprim/Sulfamethoxazole in Clinical Stenotrophomonas maltophilia isolates in China. PLoS ONE. 2016;11(6):e0157693.

Article  PubMed  PubMed Central  Google Scholar 

Hu LF, Gao LP, Ye Y, Chen X, Zhou XT, Yang HF, Liiu YY, Mei Q, Li JB. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations. J Chemother. 2014;26(5):282–6.

Article  CAS  PubMed  Google Scholar 

Hu L-F, Xu X-H, Li H-R, Gao L-P, Chen X, Sun N, Liu Y-Y, Ying H-F, Li J-B. Surveillance of antimicrobial susceptibility patterns among Stenotrophomonas maltophilia isolated in China during the 10-year period of 2005–2014. J Chemother. 2018;30(1):25–30.

Article  PubMed  Google Scholar 

Huang CR, Chen SF, Tsai NW, Chang CC, Lu CH, Chuang YC, Chien CC, Chang WN. Clinical characteristics of Stenotrophomonas maltophilia meningitis in adults: a high incidence in patients with a postneurosurgical state, long hospital staying and antibiotic use. Clin Neurol Neurosurg. 2013;115(9):1709–15.

Article  PubMed  Google Scholar 

Hussain Qadri S, Ueno Y, Saldin H, Markley Burdette J, Lee GC. Comparative antibacterial activity of the new fluoroquinolone PD 131628. Drug Invest. 1992;4:409–15.

Article  Google Scholar 

Saied WI, Merceron S, Schwebel C, Le Monnier A, Oziel J, Garrouste-Orgeas M, Marcotte G, Ruckly S, Souweine B, Darmon M. Ventilator-associated pneumonia due to Stenotrophomonas maltophilia: risk factors and outcome. J Infect. 2020;80(3):279–85.

Article  PubMed